持田製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2014/04/07 | 7,190 | 7,340 | 7,190 | 7,280 | -80 | -1.1% | 46,500 |
2014/04/04 | 7,410 | 7,430 | 7,340 | 7,360 | -50 | -0.7% | 23,600 |
2014/04/03 | 7,410 | 7,460 | 7,360 | 7,410 | ±0 | ±0% | 37,900 |
2014/04/02 | 7,500 | 7,500 | 7,410 | 7,410 | -70 | -0.9% | 35,100 |
2014/04/01 | 7,480 | 7,580 | 7,440 | 7,480 | +90 | +1.2% | 55,600 |
2014/03/31 | 7,240 | 7,420 | 7,180 | 7,390 | +130 | +1.8% | 49,000 |
2014/03/28 | 7,290 | 7,300 | 7,190 | 7,260 | -140 | -1.9% | 57,500 |
2014/03/27 | 7,300 | 7,420 | 7,260 | 7,400 | +80 | +1.1% | 70,000 |
2014/03/26 | 7,420 | 7,530 | 7,300 | 7,320 | -50 | -0.7% | 92,100 |
2014/03/25 | 7,170 | 7,540 | 7,080 | 7,370 | +180 | +2.5% | 109,000 |
2014/03/24 | 6,900 | 7,320 | 6,890 | 7,190 | +420 | +6.2% | 99,100 |
2014/03/20 | 6,850 | 6,880 | 6,740 | 6,770 | -60 | -0.9% | 44,600 |
2014/03/19 | 6,860 | 6,880 | 6,740 | 6,830 | -40 | -0.6% | 41,300 |
2014/03/18 | 6,790 | 6,920 | 6,690 | 6,870 | +250 | +3.8% | 41,000 |
2014/03/17 | 6,610 | 6,650 | 6,560 | 6,620 | -90 | -1.3% | 28,500 |
2014/03/14 | 6,830 | 6,890 | 6,680 | 6,710 | -220 | -3.2% | 72,100 |
2014/03/13 | 6,910 | 6,950 | 6,890 | 6,930 | ±0 | ±0% | 27,900 |
2014/03/12 | 6,920 | 6,970 | 6,900 | 6,930 | -50 | -0.7% | 26,600 |
2014/03/11 | 6,910 | 6,980 | 6,910 | 6,980 | +60 | +0.9% | 27,500 |
2014/03/10 | 6,910 | 6,990 | 6,830 | 6,920 | -60 | -0.9% | 22,700 |
2014/03/07 | 6,920 | 6,990 | 6,920 | 6,980 | +60 | +0.9% | 24,900 |
2014/03/06 | 6,930 | 6,930 | 6,830 | 6,920 | -10 | -0.1% | 21,300 |
2014/03/05 | 6,940 | 6,980 | 6,910 | 6,930 | +70 | +1% | 27,800 |
2014/03/04 | 6,750 | 6,900 | 6,690 | 6,860 | +60 | +0.9% | 26,600 |
2014/03/03 | 6,910 | 6,940 | 6,740 | 6,800 | -70 | -1% | 38,000 |
2014/02/28 | 6,810 | 6,900 | 6,730 | 6,870 | +80 | +1.2% | 33,700 |
2014/02/27 | 6,860 | 6,900 | 6,780 | 6,790 | -70 | -1% | 40,900 |
2014/02/26 | 6,900 | 6,910 | 6,770 | 6,860 | -50 | -0.7% | 24,700 |
2014/02/25 | 6,870 | 6,910 | 6,800 | 6,910 | +40 | +0.6% | 36,600 |
2014/02/24 | 6,800 | 6,910 | 6,720 | 6,870 | -10 | -0.1% | 50,700 |
2014/02/21 | 6,570 | 6,910 | 6,570 | 6,880 | +260 | +3.9% | 76,800 |
2014/02/20 | 6,570 | 6,750 | 6,550 | 6,620 | +60 | +0.9% | 77,400 |
2014/02/19 | 6,520 | 6,570 | 6,470 | 6,560 | -10 | -0.2% | 28,600 |
2014/02/18 | 6,440 | 6,590 | 6,430 | 6,570 | +190 | +3% | 54,500 |
2014/02/17 | 6,230 | 6,390 | 5,980 | 6,380 | -150 | -2.3% | 90,700 |
2014/02/14 | 6,490 | 6,600 | 6,360 | 6,530 | +80 | +1.2% | 72,700 |
2014/02/13 | 6,490 | 6,640 | 6,380 | 6,450 | ±0 | ±0% | 58,400 |
2014/02/12 | 6,140 | 6,490 | 6,140 | 6,450 | +410 | +6.8% | 68,800 |
2014/02/10 | 6,050 | 6,060 | 5,950 | 6,040 | +40 | +0.7% | 25,800 |
2014/02/07 | 5,960 | 6,010 | 5,870 | 6,000 | +90 | +1.5% | 32,300 |
2014/02/06 | 6,190 | 6,190 | 5,870 | 5,910 | -330 | -5.3% | 60,600 |
2014/02/05 | 6,300 | 6,370 | 6,110 | 6,240 | +440 | +7.6% | 80,100 |
2014/02/04 | 5,910 | 5,940 | 5,800 | 5,800 | -210 | -3.5% | 47,400 |
2014/02/03 | 6,050 | 6,090 | 5,990 | 6,010 | +60 | +1% | 24,700 |
2014/01/31 | 6,020 | 6,070 | 5,850 | 5,950 | -60 | -1% | 33,300 |
2014/01/30 | 6,050 | 6,170 | 5,980 | 6,010 | -210 | -3.4% | 23,800 |
2014/01/29 | 6,080 | 6,220 | 6,080 | 6,220 | +150 | +2.5% | 12,900 |
2014/01/28 | 6,180 | 6,240 | 6,060 | 6,070 | -110 | -1.8% | 43,400 |
2014/01/27 | 6,240 | 6,260 | 6,150 | 6,180 | -90 | -1.4% | 39,600 |
2014/01/24 | 6,280 | 6,360 | 6,200 | 6,270 | -110 | -1.7% | 35,500 |
2601~
2650
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム